NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Global Vision, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Vision Expands Reseller Agreement with Crest Solutions for the UK and Ireland	 - Crest Solutions to deliver Global Vision’s proofreading technologies to Pharmaceutical, Medical Device and Food & Beverage industries in both the UK and Ireland - CrestSolutions.ie / GlobalVisionInc.com
Global Vision Expands Reseller Agreement with Crest Solutions for the UK and Ireland

 

NewswireTODAY - /newswire/ - Montréal, Québec, Canada, 2014/10/14 - Crest Solutions to deliver Global Vision’s proofreading technologies to Pharmaceutical, Medical Device and Food & Beverage industries in both the UK and Ireland - CrestSolutions.ie / GlobalVisionInc.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Global Vision, the industry leader in the development of innovative proofreading technologies today announced that it has appointed Crest Solutions as its representative in the UK, expanding the territory of Crest Solutions to include both the UK and Ireland.

Today’s announcement builds on the existing reseller agreement and demonstrates the continued commitment of these two companies to deliver choice and flexibility to customers looking to implement proofreading technologies. With offices in the UK and Ireland, Crest Solutions offers customers local support from a fully certified Global Vision installation and support team.

“Companies throughout the UK and Ireland run critical business operations on Global Vision solutions every day,” said Conor O’Kelly, Sales Manager at Crest Solutions. “Through our reseller agreement, we provide customers in highly regulated industries with proven proofreading solutions that have real impact on both quality and bottom-line value. To date we have seen Global Vision solutions improving efficiencies for many companies in Ireland and we look forward to offering such opportunities to our clients in the UK.”

“Crest Solutions continues to demonstrate its importance as a Global Vision partner, adding value with its proven experience in the pharmaceutical, medical device and food & beverage industries,” said Reuben Malz, President, at Global Vision. “By working together and expanding our reseller agreement to include the UK and Ireland, we are able to provide customers with a local team that will provide both sales and services in an efficient manner.”

About Crest Solutions

Headquartered in Cork, Ireland Crest Solutions (crestsolutions.ie) has built a reputation as a leading supplier of machine vision inspection, verification and traceability solutions to regulated industries. Crest currently operates in the Pharmaceutical, Medical Device and Food & Beverage industries with operations in Ireland, the UK and Benelux.

Crest Solutions enables companies to fundamentally improve their packaging, automation and traceability activities, while supporting compliance with industry regulations. Crest Solutions adheres to strict internal and recognised standards when developing and delivering systems, including GAMP5, ISO and GS1 and is committed to delivering systems that facilitate validation and compliance with industry standards including FDA compliance according to GAMP standards and 21 CFR Part 11 when required.

About Global Vision

Global Vision (globalvisioninc.com) is the world leader in the design and delivery of Innovative Proofreading Technologies.
Global Vision’s solutions are widely interoperable and have been integrated into the packaging workflows of leading consumer packaged goods companies, printing firms and over 72% of the major pharmaceutical industry worldwide.

Global Vision’s complete suite of advanced solutions featuring text-based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork and copy related errors, providing end-to-end security at every stage of the packaging workflow. All Global Vision proofreading solutions meet FDA 21 CFR Part 11 / EMA Annex 11 requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Global Vision, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Global Vision Expands Reseller Agreement with Crest Solutions for the UK and Ireland

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Press Office - GlobalVisionInc.com 
514-624-4422 mspooner[.]globalvisioninc.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Global Vision, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Global Vision, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS
Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients
U.S. FDA Grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia
Additional Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer in South Korea
BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions
Ipsen Expands Early Development Pipeline with Simcere Zaiming’s Innovative Antibody Drug Conjugate
Ipsen Update on Phase II FALKON Trial in Patients with Ultra-rare Bone Disease, Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen Completes Acquisition of ImCheck Therapeutics, Expanding Oncology Pipeline
NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025
Ono Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Ono Receives Supplemental Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)